1. Home
  2. HRMY vs DRD Comparison

HRMY vs DRD Comparison

Compare HRMY & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • DRD
  • Stock Information
  • Founded
  • HRMY 2017
  • DRD 1895
  • Country
  • HRMY United States
  • DRD South Africa
  • Employees
  • HRMY N/A
  • DRD N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • DRD Precious Metals
  • Sector
  • HRMY Health Care
  • DRD Basic Materials
  • Exchange
  • HRMY Nasdaq
  • DRD Nasdaq
  • Market Cap
  • HRMY 1.5B
  • DRD 1.6B
  • IPO Year
  • HRMY 2020
  • DRD N/A
  • Fundamental
  • Price
  • HRMY $31.40
  • DRD $26.13
  • Analyst Decision
  • HRMY Strong Buy
  • DRD Strong Buy
  • Analyst Count
  • HRMY 9
  • DRD 2
  • Target Price
  • HRMY $50.44
  • DRD $27.50
  • AVG Volume (30 Days)
  • HRMY 912.0K
  • DRD 689.2K
  • Earning Date
  • HRMY 11-04-2025
  • DRD 01-01-0001
  • Dividend Yield
  • HRMY N/A
  • DRD 1.77%
  • EPS Growth
  • HRMY 50.44
  • DRD 68.66
  • EPS
  • HRMY 3.17
  • DRD 1.46
  • Revenue
  • HRMY $825,944,000.00
  • DRD $443,674,785.00
  • Revenue This Year
  • HRMY $20.68
  • DRD $18.10
  • Revenue Next Year
  • HRMY $15.93
  • DRD $25.92
  • P/E Ratio
  • HRMY $9.92
  • DRD $17.93
  • Revenue Growth
  • HRMY 21.13
  • DRD 26.26
  • 52 Week Low
  • HRMY $25.52
  • DRD $8.38
  • 52 Week High
  • HRMY $40.93
  • DRD $31.91
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 63.59
  • DRD 51.51
  • Support Level
  • HRMY $27.66
  • DRD $23.72
  • Resistance Level
  • HRMY $30.96
  • DRD $26.61
  • Average True Range (ATR)
  • HRMY 1.25
  • DRD 1.03
  • MACD
  • HRMY 0.54
  • DRD -0.21
  • Stochastic Oscillator
  • HRMY 92.89
  • DRD 81.49

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

Share on Social Networks: